NEW YORK CITY: Pfizer said on Monday (Tuesday in Manila) that it remains keen to acquire AstraZeneca but hinted at a hostile takeover campaign if the British company continues to rebuff its offer.
Pfizer chief executive Ian Read said he remains convinced the deal will benefit Pfizer and AstraZeneca, both of which have suffered significant patent expirations in recent years.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.